Vijay told CNBC-TV18, "HUL numbers were fantastic; I did not expect HUL to show such strong growth, even assuming some of that came from sale of asset but if you saw the volumes and pricing power they seem to have got back their pricing power. FMCG has had a very good quarter on the whole but HUL normally has been tardy company in the last quarters."
Buy HUL on dips, says Sudarshan Sukhani, s2analytics.com.
"Considering the sound business model, huge capacity expansion coupled with strong financials, we maintain our positive outlook on the stock & recommend ‘HOLD' with a DCF based price target of Rs 167," says Sushil Finance research report.
Torrent Pharma: Nirmal Bang is bullish on Torrent Pharma and has recommended buy rating with a target price of Rs 715.
DISCLAIMER: GoodReturns provides you with information covering shares, futures and options based on broker's reports as stated on various media. Investors are, however, warned that they should NOT take any buy or sell decision based on these views expressed in the article. Investors should consult their own financial and share advisors before taking purchase or sale decisions. GoodReturns does not take any responsibility for any losses incurred by investors who take their cues from the above article